Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing

被引：0
|
作者：
Jenny Chang
Sirivan Seng
June Yoo
Pamela Equivel
Sharon S. Lum
机构：
[1] Loma Linda University School of Medicine,Department of Surgery, Division of Surgical Oncology
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3389 / 3396
页数：7
相关论文
共 50 条
  • [1] Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing
    Chang, Jenny
    Seng, Sirivan
    Yoo, June
    Equivel, Pamela
    Lum, Sharon S.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (10) : 3389 - 3396
  • [2] Clinical management of high-risk breast cancer patients with variants of uncertain significance in the era of multigene panel testing
    Chang, Jenny
    Yoo, June
    Seng, Sirivan
    Esquivel, Pamela
    Lum, Sharon
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 62 - 63
  • [3] Multigene panel testing for breast cancer patients at high risk for hereditary cancer
    Shin, H-C.
    Yoo, T-K.
    Lee, E.
    Kee, H-B.
    Han, J.
    Kim, Y.
    Moon, H-G.
    Noh, D-Y.
    Han, W.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Germline variants detected by multigene panel testing in patients with suspected hereditary breast cancer
    Togashi, Yusa
    Nagahashi, Masayuki
    Kashima, Mina
    Okada, Chiho
    Kinjo, Chinatsu
    Miyazaki, Ayako
    Ueda, Mako
    Tsubamoto, Hiroshi
    Sawai, Hideaki
    Miyoshi, Yasuo
    SURGERY TODAY, 2025,
  • [5] Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
    Desmond, Andrea
    Kurian, AllisonW.
    Gabree, Michele
    Mills, Meredith A.
    Anderson, Michael J.
    Kobayashi, Yuya
    Horick, Nora
    Yang, Shan
    Shannon, Kristen M.
    Tung, Nadine
    Ford, JamesM.
    Lincoln, Stephen E.
    Ellisen, Leifw.
    JAMA ONCOLOGY, 2015, 1 (07) : 943 - 951
  • [6] Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance
    Castillo-Guardiola, Veronica
    Rosado-Jimenez, Laura
    Sarabia-Meseguer, Maria Desamparados
    Marin-Vera, Miguel
    Macias-Cerrolaza, Jose Antonio
    Garcia-Hernandez, Rosario
    Zafra-Poves, Marta
    Sanchez-Henarejos, Pilar
    Moreno-Locubiche, Maria Angeles
    Cuevas-Tortosa, Encarnacion
    Arnaldos-Carrillo, Maria
    de la Pena, Francisco Ayala
    Alonso-Romero, Jose Luis
    Noguera-Velasco, Jose Antonio
    Ruiz-Espejo, Francisco
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2022, 65 (04)
  • [7] Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer.
    Kapoor, Nimmi S.
    Curcio, Lisa D.
    Blakemore, Carlee A.
    Bremner, Amy K.
    McFarland, Rachel E.
    West, John G.
    Banks, Kimberly C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [8] Downstream Revenue Generated by Patients With Hereditary Cancer in the Multigene Panel Testing Era
    Mauer Hall, Caitlin B.
    Reys, Brian D.
    Gemmell, Amber P.
    Campbell, Connor L.
    Pirzadeh-Miller, Sara M.
    JCO ONCOLOGY PRACTICE, 2024, 20 (12)
  • [9] Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer
    Ryu, Jin-Sun
    Lee, Hye-Young
    Cho, Eun Hae
    Yoon, Kyong-Ah
    Kim, Min-Kyeong
    Joo, Jungnam
    Lee, Eun-Sook
    Kang, Han-Sung
    Lee, Seeyoun
    Lee, Dong Ock
    Lim, Myong Cheol
    Kong, Sun-Young
    CANCER SCIENCE, 2020, 111 (10) : 3912 - 3925
  • [10] Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing
    Cummings, Shelly
    Alfonso, Andrew
    Hughes, Elisha
    Kucera, Matt
    Mabey, Brent
    Singh, Nanda
    Eng, Charis
    JCO PRECISION ONCOLOGY, 2023, 7
12345